RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359

20250 citationsJournal Articlegold Open Access

Authors

Giovanni Luca Gravina · University of L'Aquila

Andrea Mancini · University of L'Aquila

Alessandro Colapietro · University of L'Aquila

Simona Delle Monache · University of L'Aquila

Roberta Sferra · University of L'Aquila

Flora Vitale · University of L'Aquila

Loredana Cristiano ·

Abstract

The journal retracts the article, "The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models" [...].

Topics & Keywords

Axon Guidance and Neuronal Signaling Hedgehog Signaling Pathway Studies Cancer Mechanisms and Therapy

Publication Details

Published in: Cancers

Volume 18, Issue 1, pp. 135-135

DOI: 10.3390/cancers18010135

Field-Weighted Citation Impact: 0.00

Command Palette

RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359

Authors

Abstract

Topics & Keywords

Publication Details